MCADD 2023 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery
September 14-16, 2023
Anti-Allergic, Anti-Infective Agents
Allergic diseases are a major health problem that affects millions of people worldwide. They constitute the fifth most common chronic diseases in all ages, and the third most frequent in children. The human and economic loads associated with these conditions are severe and harmfully affecting the socioeconomic welfare of the community. Anti-allergy drugs are the broad term for drugs known to treat allergic reactions.
Infectious diseases remain a major public health concern around the world. Anti-infectives is a broad phrase that refers to any medicine that can stop an infectious organism from spreading or destroying it completely. Anti-infectives have changed healthcare and are now essential in the treatment and prevention of a wide range of infections. Antimicrobial resistance is reducing the efficiency of several anti-infectives, which is concerning (AMR).
- Anthelmintics
- Antibiotics
- Antifungals
- Antihistamines
- Antimalarials
- Antimicrobial Resistance
- Antiprotozoals
- Antituberculosis Agents
- Antivirals
Submit your abstract Today
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt